• 1
    Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003; 163: 20527.
  • 2
    Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163: 216572.
  • 3
    Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004; 15: 76778.
  • 4
    Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, et al. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 2003; 88: 34826.
  • 5
    Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000; 109: 3268.
  • 6
    Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998; 57: 3789.
  • 7
    Follin SL, Black JN, McDermott MT. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 2003; 23: 1908.
  • 8
    Juby AG, de Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 2002; 13: 20510.
  • 9
    Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 2002; 47: 6514.
  • 10
    Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007; 357: 1799809.
  • 11
    Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, et al. Interventions to improve osteoporosis treatment following hip fracture: a prospective randomized trial. J Bone Joint Surg Am 2005; 87: 37.
  • 12
    Fisher AA, Davis MW, Rubenach SE, Sivakumaran S, Smith PN, Budge MM. Outcomes for older patients with hip fractures: the impact of orthopedic and geriatric medicine cocare. J Orthop Trauma 2006; 20: 17280.
  • 13
    Lowdon DW, Quinn C, Mole P, Leese GP. Osteoporosis assessment and treatment in older patients who have sustained a hip fracture. Scott Med J 2006; 51: 325.
  • 14
    Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, et al. Use of a case manager to improve osteoporosis treatment after hip fracture. Arch Intern Med 2007; 167: 16.
  • 15
    Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167 Suppl 10: S134.
  • 16
    National Osteoporosis Foundation. 2003 physicians' guide to prevention and treatment of osteoporosis. 2003. URL:
  • 17
    Feldstein AC, Nichols G, Orwoll E, Elmer PJ, Smith DH, Herson M, et al. The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 2005; 16: 95362.
  • 18
    Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, et al. A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 2004; 141: 36673.
  • 19
    Harrington JT, Barash HL, Day S, Lease J. Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 2005; 53: 198204.
  • 20
    Simonelli C, Killeen K, Mehle S, Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopaedic surgeons. Mayo Clin Proc 2002; 77: 3348.
  • 21
    Zafran N, Liss Z, Peled R, Sherf M, Reuveni H. Incidence and causes for failure of treatment of women with proven osteoporosis. Osteoporos Int 2005; 16: 137583.
  • 22
    Majumdar SR. Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheumatol 2008; 35: 1902.
  • 23
    McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2004; 14: 102834.
  • 24
    Murray AW, McQuillan C, Kennon B, Gallacher SJ. Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture: a comparison of two centres in the United Kingdom. Injury 2005; 36: 10804.
  • 25
    Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, et al. Osteoporosis case-manager for hip fracture patients: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med. In press.
  • 26
    Sander B, Elliott-Gibson V, Beaton DE, Bogoch ER, Maetzel A. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 2008; 90: 1197205.
  • 27
    Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, et al. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [review]. Cochrane Database Syst Rev 2008; 1:CD004523.
  • 28
    Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, et al, the Osteoporosis Methodology Group, and the Osteoporosis Research Advisory Group. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocrinol Rev 2008; 23: 51723.
  • 29
    Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al, the Osteoporosis Methodology Group, and the Osteoporosis Research Advisory Group. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocrinol Rev 2008; 23: 50816.
  • 30
    Cochrane Effective Practice and Organization of Care Group. URL:
  • 31
    Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, et al. Trends in drug prescribing for osteoporosis after hip fracture: 1995–2004. J Rheumatol 2008; 35: 31926.